Novotech, the largest independent clinical research organisation in Australia, has selected Oracle’s Siebel Clinical Trial Management System to support the company’s complete spectrum of clinical drug development and research. Novotech works with leading biotechnology and pharmaceutical companies to bring new healthcare products to the global market by offering a broad range of compliant clinical services. The company is headquartered in Australia with operations in India, New Zealand, South Korea and across Southeast Asia. The company has helped global customers conduct trials across a population base of more than 1.5 billion people in the Australasian region alone from first human exposure through to completion of Phase III trials.
Novotech has been running a bespoke system to manage their clinical trial operations. Over time, the business has grown and expanded across the Asia Pacific rim. The existing system did not accommodate the evolving business needs of Novotech as it lacked scalability and flexibility.
In order to support the company’s continued growth and an increasingly complex business, Novotech needed a system that was robust and could grow with their operations.
Novotech selected Siebel Clinical Trial Management because it met the organisation’s present needs, is a recognised leader and is built on open standards allowing the company to integrate other business applications, such as its financial system. Siebel Clinical Trial Management will also serve as a centralised repository for all investigators to collect and track relevant information about research, including personal profiles to disease specialities. Information will be readily available to manage clinical trials at different tiers